A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice

Optimal vaccines are needed for sustained suppression of SARS‐CoV‐2 and other novel coronaviruses. Here, we developed a recombinant type 5 adenovirus vector encoding the gene for the SARS‐CoV‐2 S1 subunit antigen (Ad5.SARS‐CoV‐2‐S1) for COVID‐19 immunization and evaluated its immunogenicity in mice....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Immunol
Main Authors: Kim, Eun, Weisel, Florian J., Balmert, Stephen C., Khan, Muhammad S., Huang, Shaohua, Erdos, Geza, Kenniston, Thomas W., Carey, Cara Donahue, Joachim, Stephen M., Conter, Laura J., Weisel, Nadine M., Okba, Nisreen M. A., Haagmans, Bart L., Percivalle, Elena, Cassaniti, Irene, Baldanti, Fausto, Korkmaz, Emrullah, Shlomchik, Mark J., Falo, Louis D., Gambotto, Andrea
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Immunity to infection
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250272/
https://ncbi.nlm.nih.gov/pubmed/33772778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.202149167
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares